| Identification | |
| Name: | Olaparib |
| Synonyms: | 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one;1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine; |
| CAS: | 763113-22-0 |
| Molecular Formula: | C24H23FN4O3 |
| Molecular Weight: | 434.46 |
| InChI: | InChI=1/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30) |
| Molecular Structure: | ![(C24H23FN4O3) 4-[3-(4-Cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorobenzyl]-2H-phthalazin-1-one;1-(Cyclopropy...](https://img1.guidechem.com/chem/e/dict/163/763113-22-0.jpg) |
| Properties | |
| Density: | 1.43 |
| Refractive index: | 1.702 |
| Specification: |
Olaparib (CAS NO.763113-22-0) is also named as Olaparib;1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine ; Olaparib(AZD-2281) ; Olaparib [INN] ; AZD 2281 ; KU 59436 ; KU-0059436 ; Olaparib cpd .Olaparib (CAS NO.763113-22-0) is a chemotherapeutic agent developed by KuDOS Pharmaceuticals and later by Astra Zeneca. It is an inhibitor of PARP, an enzyme involved in DNA repair. |
| Safety Data | |
 |
|
